G1 Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
29.57
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
4
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.63
|
-0.59
|
0.04
|
6.35%
|
|
2022-06-30
|
-1.02
|
-0.92
|
0.10
|
9.80%
|
|
2022-03-31
|
-0.97
|
-1.15
|
-0.18
|
-18.56%
|
|
2021-12-31
|
-1.03
|
-0.94
|
0.09
|
8.74%
|
|
2021-09-30
|
-1.00
|
-1.00
|
0.00
|
0.00%
|
|
2021-06-30
|
-0.97
|
-0.94
|
0.03
|
3.09%
|
|
2021-03-31
|
-1.07
|
-0.65
|
0.42
|
39.25%
|
|
2020-12-31
|
-0.90
|
-0.67
|
0.23
|
25.56%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.66
|
|
2021-12-31
|
-3.53
|
|
2020-12-31
|
-2.63
|
|
2019-12-31
|
-3.26
|
|
2018-12-31
|
-2.58
|
|
2017-12-31
|
-2.84
|